Theolytics Secures £19M for Oncolytic Viral Therapy Development
Theolytics, a biotechnology company based in Oxford, UK, recently secured £19M in funding to further develop oncolytic viral therapies. Backers for this round of funding included Sound Bioventures, M Ventures, Taiho Ventures, Epidarex Capital, Oxford Science Enterprises, and the University of Oxford. The company plans to use these funds to progress its lead oncolytic adenovirus, known as THEO-260, into clinical trials specifically for ovarian cancer.
Under the leadership of CEO Charlotte Casebourne Stock, Theolytics is dedicated to creating oncolytic viral therapies that can be delivered intravenously.
The main focus of the company is on advancing THEO-260 into clinical trials to improve outcomes for patients with ovarian cancer, especially those who have limited treatment options available. THEO-260 is described as a next-generation oncolytic adenovirus designed to target and destroy cancer cells, as well as cancer-associated fibroblasts in ovarian cancer patient tumor samples.
In addition to THEO-260, Theolytics is also working on other pipeline programs in preclinical development. These include novel candidates aimed at colorectal cancer and hematological malignancies, both of which have significant unmet medical needs. The company's research focuses on developing therapies that can effectively target cancer cells and their microenvironment, with the ultimate goal of providing better treatment options for patients facing these challenging diseases.
They've invested in Theolytics
Get to know these Healthtech investors
| # | Investor | Sector | Stage | Activity | Team | Connect |
|---|---|---|---|---|---|---|
1 |  Sound Bioventures | 1 investment(s) investment(s) | more info | |||
2 |  M Ventures | 7 investment(s) investment(s) | 19 contacts contacts | |||
3 |  Taiho Ventures | 1 investment(s) investment(s) | more info | |||
4 |  Epidarex Capital | 4 investment(s) investment(s) | more info | |||
5 |  Oxford Science Enterprises | 21 investment(s) investment(s) | more info |
Click here for a full list of 6,528+ startup investors in the UK